about
Bias in error estimation when using cross-validation for model selectionPutative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agentsIterative class discovery and feature selection using Minimal Spanning TreesUsing CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerNCI-60 whole exome sequencing and pharmacological CellMiner analysesHigh resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMinerThe NCI-60 Methylome and Its Integration into CellMiner.CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.DNA fingerprinting of the NCI-60 cell line panel.Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Microarray-based analysis of differential gene expression between infective and noninfective larvae of Strongyloides stercoralis.Construct and Compare Gene Coexpression Networks with DAPfinder and DAPview.DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasiaAsparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.Identification of novel mutations by exome sequencing in African American colorectal cancer patientsG4 motifs correlate with promoter-proximal transcriptional pausing in human genes.Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.High recombination rates and hotspots in a Plasmodium falciparum genetic crossRedefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells.Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugsThe clinical relevance of cancer cell lines.rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RReduced Representation Bisulfite Sequencing Determination of Distinctive DNA Hypermethylated Genes in the Progression to Colon Cancer in African AmericansChromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapyTargeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.Metabolic network failures in Alzheimer's disease: A biochemical road map.Next-generation sequencing in African Americans with colorectal cancer.Peril beyond the winner's curse: A small sample size is the bane of biomarker discovery.Calculating confidence intervals for prediction error in microarray classification using resampling.Targeted Exome Sequencing Outcome Variations of Colorectal Tumors within and across Two Sequencing Platforms
P50
Q21284241-561291BB-5B42-4F6D-AB6D-2C77126A1D85Q24297639-51A349FB-0826-4404-9999-4D39C4C97AC0Q24795482-7B271624-3C89-4189-B1D0-F55A0AF535E5Q26826831-1411D81E-B4E4-4B66-8F35-A282C3E7F31AQ27320602-14EA1E67-CA70-4249-8F70-1CDCD15E0329Q28540834-485A093E-C718-4B48-94E4-1E0640337478Q28541555-E48E66CA-A59E-4C29-A500-1C43447F9D8DQ30490461-B9FE2CCC-539D-44CC-BD60-5DA72E6C74CDQ33472990-A46019DD-3B64-4E42-B537-B1B10476A3CCQ33608214-3AB09099-1F6C-48DD-9451-1CE77902CF4EQ33855041-8BBBA026-48BE-48F9-9C8E-676240E5E59CQ33900095-292A2E26-F574-4E3F-ABF2-3E04E118E24AQ33960783-98C89874-9A23-4D82-9996-E5930AF6A756Q34000385-6F115DF1-E839-4D19-9762-0EDA62BE4523Q34011217-C66CE081-72DE-416B-96D4-71B94EA3209BQ34349236-79A1BFB3-B131-40FF-AE85-92754081DE44Q34977426-A1170B27-B89F-4413-85DC-671A9928A78CQ35088017-C62BEB14-45C7-4ECF-B0F9-EC6F3A168B8CQ35268479-9FD86A03-B1FD-405E-9AB5-4B7901D0C2D9Q35557751-34ECA6C7-6497-4869-A14D-FC7FBCFA7955Q35558646-BA57BC65-D464-4D29-ABCA-09FFFCC072CFQ35575176-886B607A-BD5F-498E-8B3C-7AD8E041E9A9Q36069053-9F46A630-168A-4F0E-ACC4-7A4DB1BA2095Q36143956-A1DA97F3-3D32-4091-8297-18249A917332Q36345965-EBAB7DDA-57ED-41D6-B5D1-B1A4E8CB9B8EQ36487139-267E78B4-3FCF-4B66-9B58-33899453E277Q36502944-C7771815-5516-45CB-B29A-F1A6291CD814Q36533581-0386BD61-2DA7-4772-9A03-9E4DAF4F0412Q36772043-9A715025-B8DF-4C3E-B08B-18C72EC00C40Q36953572-38639EE7-F845-47E3-9AFB-6C764BC3CC5AQ37002981-57152834-A3F8-4665-9CF7-DC8C0D68449AQ37256765-8C9C7B21-ED7B-45DE-8DD4-13436832A580Q37271984-E60B6AC3-FE02-4187-A3DE-B156995C9B4DQ37686903-C96AE201-242B-487B-A6D8-19494C317F7AQ38747834-F6A5F105-8662-484D-B367-8412D48D87CEQ38877855-1BB154D8-6D4E-4BA5-8882-D18C96C3FFB2Q42564501-B49E88DC-FC1D-4EF6-AEB4-96CFFCC99384Q47240642-3FBE1F73-2FDE-44B9-9DF9-522DF04073D7Q53034960-7B94DC15-8A78-474D-B90F-E37C7E212DCFQ88174002-6DBAC59A-BAD3-4777-A8FD-99A18A50286E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sudhir Varma
@ast
Sudhir Varma
@en
Sudhir Varma
@es
Sudhir Varma
@nl
Sudhir Varma
@sl
type
label
Sudhir Varma
@ast
Sudhir Varma
@en
Sudhir Varma
@es
Sudhir Varma
@nl
Sudhir Varma
@sl
prefLabel
Sudhir Varma
@ast
Sudhir Varma
@en
Sudhir Varma
@es
Sudhir Varma
@nl
Sudhir Varma
@sl
P1053
N-8763-2014
P106
P21
P31
P3829
P496
0000-0002-4096-4782
P569
2000-01-01T00:00:00Z